Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry

Journal of Lipid Research - Tập 56 - Trang 936-943 - 2015
Mina Mirzaian1, Gertjan Kramer1, Ben J.H.M. Poorthuis1
1Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

Tài liệu tham khảo

Eckhardt, 2008, The role and metabolism of sulfatide in the nervous system, Mol. Neurobiol., 37, 93, 10.1007/s12035-008-8022-3 Takahashi, 2012, Role of sulfatide in normal and pathological cells and tissues, J. Lipid Res., 53, 1437, 10.1194/jlr.R026682 Wittke, 2004, Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution, Acta Neuropathol., 108, 261, 10.1007/s00401-004-0883-6 Liu, 2010, Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry, Mol. Cancer., 9, 186, 10.1186/1476-4598-9-186 Niimura, 2008, Metabolic responses of sulfatide and related glycolipids in Madin-Darby canine kidney (MDCK) cells under osmotic stresses, Comp. Biochem. Physiol., 149, 161, 10.1016/j.cbpb.2007.09.002 StettnerP.BourgeoisS.MarschingC.Traykova-BrauchM.PorubskyS.NordstromV.HopfC.KostersR.SandhoffR.WiegandtH.. Sulfatides are required for renal adaptation to chronic metabolic acidosis. Proc. Natl. Acad. Sci. U S A., 110: 9998–10003. Ishizuka, 1997, Chemistry and functional distribution of sulfoglycolipids, Prog. Lipid Res., 36, 245, 10.1016/S0163-7827(97)00011-8 Buschard, 2006, C16:0 sulfatide inhibits insulin secretion in rat beta-cells by reducing the sensitivity of KATP channels to ATP inhibition, Diabetes., 55, 2826, 10.2337/db05-1355 van Zyl, 2010, Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice, J. Neurochem., 112, 282, 10.1111/j.1471-4159.2009.06458.x Colsch, 2004, Characterization of the ceramide moieties of sphingoglycolipids from mouse brain by ESI-MS/MS: identification of ceramides containing sphingadienine, J. Lipid Res., 45, 281, 10.1194/jlr.M300331-JLR200 Von FiguraK. G. V.JaekenJ.2001. Metachromatic leukodystrophy. In The metabolic and molecular basis of inherited disease. C. R. Scriver, A. L. Beaudet, D. Valle, and W. S. Sly, editors. McGraw Hill, New York. 3695–3724. Toda, 1989, Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy, Biochem. Biophys. Res. Commun., 159, 605, 10.1016/0006-291X(89)90037-5 Cui, 2008, Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies, Glycoconj. J., 25, 147, 10.1007/s10719-007-9067-7 Natowicz, 1996, Urine sulfatides and the diagnosis of metachromatic leukodystrophy, Clin. Chem., 42, 232, 10.1093/clinchem/42.2.232 Whitfield, 2001, Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry, Mol. Genet. Metab., 73, 30, 10.1006/mgme.2001.3165 Hess, 1996, Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy, Proc. Natl. Acad. Sci. USA., 93, 14821, 10.1073/pnas.93.25.14821 Blomqvist, 2011, Accumula­tion of lysosulfatide in the brain of arylsulfatase A-deficient mice, Lipids Health Dis., 10, 28, 10.1186/1476-511X-10-28 Ramakrishnan, 2007, Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy, J. Neurosci., 27, 9482, 10.1523/JNEUROSCI.2287-07.2007 Berná, 1999, Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies, Anal. Biochem., 269, 304, 10.1006/abio.1999.4002 Nonaka, 1979, Simultaneous determination of picomole levels of gluco- and galactocerebroside, monogalactosyl diglyceride, and sulfatide by high performance liquid chromatography, Biochim. Biophys. Acta., 572, 423, 10.1016/0005-2760(79)90149-8 Tan, 2010, Biochemical profiling to predict disease severity in metachromatic leukodystrophy, Mol. Genet. Metab., 99, 142, 10.1016/j.ymgme.2009.09.006 Hsu, 1998, Electrospray ionization tandem mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species expressed in brain and in pancreatic islets, Biochim. Biophys. Acta., 1392, 202, 10.1016/S0005-2760(98)00034-4 Kuchař, 2013, Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy, 425, 153 Han, 2014, Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy, Rapid Commun. Mass Spectrom., 28, 587, 10.1002/rcm.6823 Barcenas, 2014, Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry, Clin. Chim. Acta, 433, 39, 10.1016/j.cca.2013.12.016 Matzner, 2007, Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy, Molecular medicine (Cambridge, Mass), 13, 471, 10.2119/2007-00063.Matzner Folch, 1957, A simple method for the isolation and purification of total lipides from animal tissues, J. Biol. Chem., 226, 497, 10.1016/S0021-9258(18)64849-5 Vance, 1967, Quantitative determination of the neutral glycosyl ceramides in human blood, J. Lipid Res., 8, 621, 10.1016/S0022-2275(20)38884-2 Bligh, 1959, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 37, 911, 10.1139/y59-099 Sugiyama, 1999, A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction, Anal. Biochem., 274, 90, 10.1006/abio.1999.4245 Haimi, 2009, Instrument-independent software tools for the analysis of MS-MS and LC-MS lipidomics data, Methods in molecular biology (Clifton, N.J), 580, 285 Nonaka, 1979, Levels of cerebrosides, sulfatides, and galactosyl diglycerides in different regions of rat brain. Change during maturation and distribution in subcellular fractions of gray and white matter of sheep brain, Biochim. Biophys. Acta., 572, 432, 10.1016/0005-2760(79)90150-4 Morichika, 1996, Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma, Cancer., 78, 43, 10.1002/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.0.CO;2-I Marbois, 2000, Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry, Biochim. Biophys. Acta., 1484, 59, 10.1016/S1388-1981(99)00201-2 Aerts, 2008, Elevated globotriaosylsphingosine is a hallmark of Fabry disease, Proc. Natl. Acad. Sci. USA., 105, 2812, 10.1073/pnas.0712309105 Gold, 2013, Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry, Clin. Chem., 59, 547, 10.1373/clinchem.2012.192138 Mistry, 2010, Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage, Proc. Natl. Acad. Sci. USA., 107, 19473, 10.1073/pnas.1003308107 Dekker, 2011, Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response, Blood., 118, e118, 10.1182/blood-2011-05-352971